Biogen Inc.

NAS : BIIB
Pharmaceuticals
Cambridge MA
Revenue (US$ Millions)$8,508
Revenue Growth (%)46.53%
Net Income (Millions)$2,935
Common Shares Outstanding (Millions)$235
Earnings per Share$12.37
Price To Earnings Ratio29.04
Total Equity (Millions)$10,809
Profit Margin 134.49%
Return on Equity34.05%
Long Term Debt (US$ Millions)$582
Debt To Equity Ratio (%)0.05%
Market Capitalization (US$ Millions)$79,622
Total Assets (US$ Millions)$14,317
Return on Assets (%)24.74
Current Assets (US$ Millions)$4,673
Inventories (US$ Millions)$804
Current Liabilities (US$ Millions)$2,220
Cost of Goods Sold (US$ Millions)$1,171
Asset Turnover0.59
Inventory Turnover1.6